Fluoxetine, another 5‐HT uptake inhibitor, has broader effects; it inhibits SERT activity in CRC cells, downregulates lactate transporters, disrupts mitochondrial function, and reduces tumor growth and microvascular density [246]. Here, SLC6A4 is linked to colorectal carcinoma.